144 related articles for article (PubMed ID: 10363029)
21. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.
Marchini S; Damia G; Broggini M; Pennella G; Ripamonti M; Marsiglio A; Geroni C
Cancer Res; 2001 Mar; 61(5):1991-5. PubMed ID: 11280757
[TBL] [Abstract][Full Text] [Related]
22. Binding to DNA, cellular uptake and biological activity of a distamycin-ellipticine hybrid molecule.
Bailly C; Leclere V; Pommery N; Colson P; Houssier C; Rivalle C; Bisagni E; Hénichart JP
Anticancer Drug Des; 1993 Apr; 8(2):145-64. PubMed ID: 8494604
[TBL] [Abstract][Full Text] [Related]
23. Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.
Pezzoni G; Grandi M; Biasoli G; Capolongo L; Ballinari D; Giuliani FC; Barbieri B; Pastori A; Pesenti E; Mongelli N
Br J Cancer; 1991 Dec; 64(6):1047-50. PubMed ID: 1764367
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationship of a series of C-terminus modified aminoalkyl, diaminoalkyl- and anilino-containing analogues of the benzoic acid mustard distamycin derivative tallimustine: synthesis, DNA binding and cytotoxicity studies.
Brooks N; Hartley JA; Simpson JE; Wright SR; Woo S; Centioni S; Fontaine MD; McIntyre TE; Lee M
Bioorg Med Chem; 1997 Aug; 5(8):1497-507. PubMed ID: 9313856
[TBL] [Abstract][Full Text] [Related]
25. Synergistic antineoplastic and cytogenetic effects by the combined action of two homo-aza-steroidal esters of nitrogen mustards on P388 and L1210 leukaemias in vivo and in vitro.
Nikolaropoulos S; Tsavdaridis D; Arsenou E; Papageorgiou A; Karaberis E; Mourelatos D
Anticancer Res; 2000; 20(4):2745-51. PubMed ID: 10953353
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo activity of 1-aryl-3-(2-chloroethyl) urea derivatives as new antineoplastic agents.
Lacroix J; Gaudreault RC; Pagé M; Joly LP
Anticancer Res; 1988; 8(4):595-8. PubMed ID: 3052247
[TBL] [Abstract][Full Text] [Related]
27. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
Catsoulacos P; Catsoulacos D
Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677
[TBL] [Abstract][Full Text] [Related]
28. Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies.
Geroni C; Pesenti E; Tagliabue G; Ballinari D; Mongelli N; Broggini M; Erba E; D'Incalci M; Spreafico F; Grandi M
Int J Cancer; 1993 Jan; 53(2):308-14. PubMed ID: 8425770
[TBL] [Abstract][Full Text] [Related]
29. Ethanol mustard cytotoxicity in vitro toward murine leukemia and bone marrow progenitor cells.
Naujokaitis SA; Fisher JM; Rabinovitz M
Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):305-18. PubMed ID: 7302378
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
[TBL] [Abstract][Full Text] [Related]
31. Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters.
Koutsourea AI; Fousteris MA; Arsenou ES; Papageorgiou A; Pairas GN; Nikolaropoulos SS
Bioorg Med Chem; 2008 May; 16(9):5207-15. PubMed ID: 18353651
[TBL] [Abstract][Full Text] [Related]
32. Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine).
Ciomei M; Pastori W; Capolongo L; Geroni C; Melegaro G; Pennella G; Grandi M
Br J Cancer; 1995 Dec; 72(6):1504-8. PubMed ID: 8519667
[TBL] [Abstract][Full Text] [Related]
33. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA
J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, solvolytic stability and cytotoxicity of a modified derivative of CPzI, a pyrazole analog of the alkylation subunit of the antitumor agent CC-1065: effect of the nitrogen substitution on the functional reactivity.
Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Capolongo L; Cozzi P; Geroni C; Mongelli N
Farmaco; 1997 Dec; 52(12):717-23. PubMed ID: 9648275
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and cytotoxic activity of 1-(3-oxoprop-1-enyl)-2-pyridones.
Ho LK; Knaus EE; Allen TM; Fathi-Afshar R
Drug Des Deliv; 1988 Feb; 2(3):227-37. PubMed ID: 3255317
[TBL] [Abstract][Full Text] [Related]
37. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and preliminary cytotoxicity of nitrogen mustard derivatives of distamycin A.
Wang Y; Wright SC; Larrick JW
Bioorg Med Chem Lett; 2003 Feb; 13(3):459-61. PubMed ID: 12565950
[TBL] [Abstract][Full Text] [Related]
39. In vivo antitumor activity of 5-hydroxy-6-[N,N-bis(2-chloroethyl)aminomethyl]naphthalene-1,8- carbolactone.
Riondel J; Boitard M; Bouaziz Z; Fillion H
Pharmazie; 1992 Jan; 47(1):67-8. PubMed ID: 1608991
[No Abstract] [Full Text] [Related]
40. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
Coley HM; Mongelli N; D'Incalci M
Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
